Pre-eclampsia: Universal Screening or Universal Prevention for Low andMiddle-Income Settings?

Abstract Pre-eclampsia (PE) is a severe disorder that affects up to 8% of all pregnancies and represents an important cause of maternal and perinatal morbidity and mortality. The screening of the disease is a subject of studies, but the complexity and uncertainties regarding its etiology make this objective a difficult task. In addition, the costs related to screening protocols, the heterogeneity of the most affected populations and the lack of highly effective prevention methods reduce the potential of current available algorithms for screening. Thus, the National Specialized Commission of Hypertension in Pregnancy of the Brazilian Association of Gynecology and Obstetrics Federation (Febrasgo, in the Portuguese acronym) (NSC Hypertension in Pregnancy of the Febrasgo) considers that there are no screening algorithms to be implemented in the country to date and advocates that Aspirin and calcium should be widely used.

Bibliographic Details

Main Authors:	Oliveira,Leandro Gustavo De, Diniz,Angélica Lemos Debs, Prado,Caio Antônio de Campos, Cunha Filho,Edson Vieira Da, Souza,Francisco Lázaro Pereira De, Korkes,Henri Augusto, Ramos,José Geraldo, Costa,Maria Laura, Corrêa Junior,Mário Dias, Sass,Nelson, Cavalli,Ricardo De Carvalho, Martins-Costa,Sérgio Hofmeister De Almeida, Peraçoli,José Carlos
Format:	Digital revista
Language:	English
Published:	Federação Brasileira das Sociedades de Ginecologia e Obstetrícia 2021
Online Access:	http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-72032021000100061
Tags:	Add Tag No Tags, Be the first to tag this record!